Teleflex (NYSE:TFX – Get Free Report) and Spectral AI (NASDAQ:MDAI – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, analyst recommendations and risk.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Teleflex and Spectral AI, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Teleflex | 1 | 5 | 4 | 2 | 2.58 |
| Spectral AI | 1 | 0 | 1 | 1 | 2.67 |
Teleflex presently has a consensus target price of $152.90, indicating a potential upside of 24.88%. Spectral AI has a consensus target price of $4.00, indicating a potential upside of 151.57%. Given Spectral AI’s stronger consensus rating and higher possible upside, analysts clearly believe Spectral AI is more favorable than Teleflex.
Risk & Volatility
Insider and Institutional Ownership
95.6% of Teleflex shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 0.7% of Teleflex shares are owned by company insiders. Comparatively, 13.7% of Spectral AI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Teleflex and Spectral AI’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Teleflex | -39.67% | 11.93% | 5.44% |
| Spectral AI | -69.27% | N/A | -78.56% |
Valuation and Earnings
This table compares Teleflex and Spectral AI”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Teleflex | $1.99 billion | 2.60 | -$905.64 million | ($23.29) | -5.26 |
| Spectral AI | $19.65 million | 2.60 | -$7.57 million | ($0.35) | -4.54 |
Spectral AI has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.
Summary
Spectral AI beats Teleflex on 8 of the 15 factors compared between the two stocks.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
About Spectral AI
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
